Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.11 +0.05 (+83.33%)
At close: Oct 1, 2026 · 4:00 PM EDT

Mosaic ImmunoEngineering (CPMV) Gains from Sales and Divestitures (2013)

Updated

Mosaic ImmunoEngineering's Gains from Sales and Divestitures came in at -$1,276 for FY2018.

Analysis

Mosaic ImmunoEngineering (CPMV) Gains from Sales and Divestitures (2013) Analysis & Trends

Going back to FY2011, Mosaic ImmunoEngineering's Gains from Sales and Divestitures data covers 5 years.

  • The FY2018 figure represents the lowest annual Gains from Sales and Divestitures in data going back to FY2011.
  • Per Business Quant, earlier years put Gains from Sales and Divestitures at -$642.00 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Mosaic ImmunoEngineering 796,635.07 796,635.07 -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2013 4,072.00
Feb 28, 2013 -4,072.00
API Access

Mosaic ImmunoEngineering Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=CPMV&period=max&api_key=YOUR_API_KEY